ICAHN CARL C 13D and 13G filings for Enzon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-19 4:30 pm Purchase | 2024-12-19 | 13D | Enzon Pharmaceuticals, Inc. ENZN | ICAHN CARL C | 36,056,636 48.600% | 36,056,636 (New Position) | Filing |
| 2024-08-19 5:47 pm Sale | 2024-08-19 | 13D | Enzon Pharmaceuticals, Inc. ENZN | ICAHN CARL C | 0 0.000% | -36,056,636 (Position Closed) | Filing |
| 2020-10-14 4:58 pm Purchase | 2020-10-09 | 13D | Enzon Pharmaceuticals, Inc. ENZN | ICAHN CARL C | 36,056,636 48.600% | 36,056,636 (New Position) | Filing |
| 2020-09-01 5:01 pm Unchanged | 2020-09-01 | 13D | Enzon Pharmaceuticals, Inc. ENZN | ICAHN CARL C | 0 0.000% | 0 (Unchanged) | Filing |
| 2020-08-07 9:45 pm Unchanged | 2020-08-04 | 13D | Enzon Pharmaceuticals, Inc. ENZN | ICAHN CARL C | 0 0.000% | 0 (Unchanged) | Filing |